InvestorsHub Logo

drkazmd65

10/31/14 9:20 AM

#103099 RE: Snowy_Owl #103097

Absolutely Detonate!

Plenty of work to be done first before NNVC has a shot at a piece of that very lucrative pie - but IF Ebolacide2 looks good in initial testing on animals and cell lines - AND if Flucide TOX data can be used as a proxy for Ebolacide2's likely safety (in a general sense anyway),...

NNVC could indeed find themselves with access to that market. The limited competition is NOT that far ahead AND is likely to have issues in scaling up their own production.

So while Flucide plods its way through TOX testing in preparation for an IND submission to the FDA sometime next year (with luck) - Ebolacide2 could get our company's foot in that door.